Seminars in Hematology
Volume 46, Issue 2 , Pages 127-132, April 2009

The Role of High-Dose Therapy With Autologous Stem Cell Support in the Era of Novel Agents

  • Michel Attal

      Affiliations

    • Centre Hospitalier de Purpan, Toulouse, France
    • Corresponding Author InformationAddress correspondence to Michel Attal, MD, Centre Hospitalier de Purpan, Place du Dr Baylac, 31059 Toulouse, France
    • ,
  • Jean-Luc Harousseau

      Affiliations

    • Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(09)00034-1

doi:10.1053/j.seminhematol.2009.02.006

Seminars in Hematology
Volume 46, Issue 2 , Pages 127-132, April 2009

Article Tools